247 related articles for article (PubMed ID: 21396797)
1. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
[TBL] [Abstract][Full Text] [Related]
3. The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.
Chen G; Hardy K; Pagler E; Ma L; Lee S; Gerondakis S; Daley S; Shannon MF
J Immunol; 2011 Nov; 187(9):4483-91. PubMed ID: 21940679
[TBL] [Abstract][Full Text] [Related]
4. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
6. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
8. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
9. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
[TBL] [Abstract][Full Text] [Related]
10. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
11. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
[TBL] [Abstract][Full Text] [Related]
12. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
13. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
14. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
[TBL] [Abstract][Full Text] [Related]
15. PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.
Comerford I; Litchfield W; Kara E; McColl SR
PLoS One; 2012; 7(9):e45095. PubMed ID: 23028778
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine.
Qin X; Guo BT; Wan B; Fang L; Lu L; Wu L; Zang YQ; Zhang JZ
J Immunol; 2010 Aug; 185(3):1855-63. PubMed ID: 20622114
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
Miller SD; McMahon EJ; Schreiner B; Bailey SL
Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
Shang SQ; Li J; Li SQ; Cao YL
Int J Clin Exp Med; 2015; 8(11):20645-51. PubMed ID: 26884985
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
Zhang J; Cheng Y; Cui W; Li M; Li B; Guo L
J Neuroimmunol; 2014 Jan; 266(1-2):56-63. PubMed ID: 24332164
[TBL] [Abstract][Full Text] [Related]
20. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
